Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Mrdovic

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Anatolian Journal of Cardiology|June 29, 2018
Prognostic impact of renal dysfunction on long-term mortality in patients with preserved, moderately impaired, and severely impaired left ventricular systolic function following myocardial infarctionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Journal of Interventional Cardiology|November 28, 2019
Using the RISK-PCI Score in the Long-Term Prediction of Major Adverse Cardiovascular Events and Mortality after Primary Percutaneous Coronary InterventionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 23, 2016
Gender differences in the prognostic impact of chronic kidney disease in patients with left ventricular systolic dysfunction following ST elevation myocardial infarction treated with primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Anatolian Journal of Cardiology|September 9, 2021
Impact of kidney function on the occurrence of new-onset atrial fibrillation in patients with ST-elevation myocardial infarctionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Scandinavian Cardiovascular Journal : SCJ|February 13, 2023
Sudden cardiac death in long-term follow-up in patients treated with primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Clinics and Practice|June 25, 2025
Predictors of Major Adverse Cardiovascular Events in Stable Patients After ST Elevation Myocardial InfarctionLidija Savic, Damjan Simic, Ratko Lasica, et al.
CJC Open|January 28, 2025
Prognostic Impact of Insulin-Treated and Non-Insulin-Treated Diabetes in Patients with a Reduced Ejection Fraction After ST-Elevation Myocardial InfarctionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Journal of Interventional Cardiology|December 19, 2022
The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry AnalysisLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Journal of Personalized Medicine|July 29, 2023
Prognostic Impact of Non-Cardiac Comorbidities on Long-Term Prognosis in Patients with Reduced and Preserved Ejection Fraction following Acute Myocardial InfarctionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Journal of Interventional Cardiology|June 12, 2009
Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI studyIgor Mrdovic, Lidija Savic, Jovan Perunicic, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Anatolian Journal of Cardiology|June 29, 2018
Prognostic impact of renal dysfunction on long-term mortality in patients with preserved, moderately impaired, and severely impaired left ventricular systolic function following myocardial infarctionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Journal of Interventional Cardiology|November 28, 2019
Using the RISK-PCI Score in the Long-Term Prediction of Major Adverse Cardiovascular Events and Mortality after Primary Percutaneous Coronary InterventionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 23, 2016
Gender differences in the prognostic impact of chronic kidney disease in patients with left ventricular systolic dysfunction following ST elevation myocardial infarction treated with primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Anatolian Journal of Cardiology|September 9, 2021
Impact of kidney function on the occurrence of new-onset atrial fibrillation in patients with ST-elevation myocardial infarctionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Scandinavian Cardiovascular Journal : SCJ|February 13, 2023
Sudden cardiac death in long-term follow-up in patients treated with primary percutaneous coronary interventionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Clinics and Practice|June 25, 2025
Predictors of Major Adverse Cardiovascular Events in Stable Patients After ST Elevation Myocardial InfarctionLidija Savic, Damjan Simic, Ratko Lasica, et al.
CJC Open|January 28, 2025
Prognostic Impact of Insulin-Treated and Non-Insulin-Treated Diabetes in Patients with a Reduced Ejection Fraction After ST-Elevation Myocardial InfarctionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Journal of Interventional Cardiology|December 19, 2022
The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry AnalysisLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Journal of Personalized Medicine|July 29, 2023
Prognostic Impact of Non-Cardiac Comorbidities on Long-Term Prognosis in Patients with Reduced and Preserved Ejection Fraction following Acute Myocardial InfarctionLidija Savic, Igor Mrdovic, Milika Asanin, et al.
Journal of Interventional Cardiology|June 12, 2009
Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI studyIgor Mrdovic, Lidija Savic, Jovan Perunicic, et al.
Pageof 5